Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Sridhar V. Basavaraju is active.

Publication


Featured researches published by Sridhar V. Basavaraju.


JAMA | 2013

Raccoon Rabies Virus Variant Transmission Through Solid Organ Transplantation

Neil M. Vora; Sridhar V. Basavaraju; Katherine A. Feldman; Christopher D. Paddock; Lillian A. Orciari; Steven Gitterman; Stephanie Griese; Ryan M. Wallace; Maria A. Said; Dianna M. Blau; Gennaro Selvaggi; Andres Velasco-Villa; Jana M. Ritter; Pamela A. Yager; Agnes Kresch; Mike Niezgoda; Jesse D. Blanton; Valentina Stosor; Edward M. Falta; G. Marshall Lyon; Teresa R. Zembower; Natalia Kuzmina; Prashant K. Rohatgi; Sergio Recuenco; Sherif R. Zaki; Inger K. Damon; Richard Franka; Matthew J. Kuehnert

IMPORTANCE The rabies virus causes a fatal encephalitis and can be transmitted through tissue or organ transplantation. In February 2013, a kidney recipient with no reported exposures to potentially rabid animals died from rabies 18 months after transplantation. OBJECTIVES To investigate whether organ transplantation was the source of rabies virus exposure in the kidney recipient, and to evaluate for and prevent rabies in other transplant recipients from the same donor. DESIGN Organ donor and all transplant recipient medical records were reviewed. Laboratory tests to detect rabies virus-specific binding antibodies, rabies virus neutralizing antibodies, and rabies virus antigens were conducted on available specimens, including serum, cerebrospinal fluid, and tissues from the donor and the recipients. Viral ribonucleic acid was extracted from tissues and amplified for nucleoprotein gene sequencing for phylogenetic comparisons. MAIN OUTCOMES AND MEASURES Determination of whether the donor died from undiagnosed rabies and whether other organ recipients developed rabies. RESULTS In retrospect, the donors clinical presentation (which began with vomiting and upper extremity paresthesias and progressed to fever, seizures, dysphagia, autonomic dysfunction, and brain death) was consistent with rabies. Rabies virus antigen was detected in archived autopsy brain tissue collected from the donor. The rabies viruses infecting the donor and the deceased kidney recipient were consistent with the raccoon rabies virus variant and were more than 99.9% identical across the entire N gene (1349/1350 nucleotides), thus confirming organ transplantation as the route of transmission. The 3 other organ recipients remained asymptomatic, with rabies virus neutralizing antibodies detected in their serum after completion of postexposure prophylaxis (range, 0.3-40.8 IU/mL). CONCLUSIONS AND RELEVANCE Unlike the 2 previous clusters of rabies virus transmission through solid organ transplantation, there was a long incubation period in the recipient who developed rabies, and survival of 3 other recipients without pretransplant rabies vaccination. Rabies should be considered in patients with acute progressive encephalitis of unexplained etiology, especially for potential organ donors. A standard evaluation of potential donors who meet screening criteria for infectious encephalitis should be considered, and risks and benefits for recipients of organs from these donors should be evaluated.


Transfusion | 2015

Transfusion-related adverse reactions reported to the National Healthcare Safety Network Hemovigilance Module, United States, 2010 to 2012

Alexis Harvey; Sridhar V. Basavaraju; Koo-Whang Chung; Matthew J. Kuehnert

In 2010, health care facilities in the United States began voluntary enrollment in the National Healthcare Safety Network (NHSN) Hemovigilance Module. Participants report transfusion practices; red blood cell, platelet (PLT), plasma, and cryoprecipitate units transfused; and transfusion‐related adverse reactions and process errors to the Centers for Disease Control and Prevention through a secure, Internet‐accessible surveillance application available to transfusing facilities.


Transfusion | 2016

Declining blood collection and utilization in the United States

Koo-Whang Chung; Sridhar V. Basavaraju; Yi Mu; Katharina Van Santen; Kathryn A. Haass; Richard A. Henry; James J. Berger; Matthew J. Kuehnert

The Department of Health and Human Services National Blood Collection and Utilization Survey (NBCUS) has been conducted biennially since 1997. Data are used to estimate national blood collection and utilization.


Transfusion | 2017

Continued decline in blood collection and transfusion in the United States-2015

Katherine Ellingson; Mathew R. P. Sapiano; Kathryn A. Haass; Alexandra A. Savinkina; Misha L. Baker; Koo-Whang Chung; Richard A. Henry; James J. Berger; Matthew J. Kuehnert; Sridhar V. Basavaraju

In 2011 and 2013, the National Blood Collection and Utilization Survey (NBCUS) revealed declines in blood collection and transfusion in the United States. The objective of this study was to describe blood services in 2015.


Vox Sanguinis | 2010

Reduced risk of transfusion‐transmitted HIV in Kenya through centrally co‐ordinated blood centres, stringent donor selection and effective p24 antigen‐HIV antibody screening

Sridhar V. Basavaraju; Jane Mwangi; J. Nyamongo; Clement Zeh; D. Kimani; Ray W. Shiraishi; R. Madoda; Jully A. Okonji; W. Sugut; S. Ongwae; John P. Pitman; Lawrence H. Marum

Background  Following a 1994 study showing a high rate of transfusion‐associated HIV, Kenya implemented WHO blood safety recommendations including: organizing the Kenya National Blood Transfusion Service (NBTS), stringent blood donor selection, and universal screening with fourth‐generation p24 antigen and HIV antibody assays. Here, we estimate the risk of transfusion‐associated HIV transmission in Kenya resulting from NBTS laboratory error and consider the potential safety benefit of instituting pooled nucleic acid testing (NAT) to reduce window period transmission.


Emerging Infectious Diseases | 2014

Encephalitis caused by pathogens transmitted through organ transplants, United States, 2002-2013.

Sridhar V. Basavaraju; Matthew J. Kuehnert; Sherif R. Zaki; James J. Sejvar

Donor-derived infectious encephalitis among transplant recipients is rare and may not be recognized by clinicians.


Morbidity and Mortality Weekly Report | 2016

Survey of Blood Collection Centers and Implementation of Guidance for Prevention of Transfusion-Transmitted Zika Virus Infection--Puerto Rico, 2016.

Amber M. Vasquez; Mathew R. P. Sapiano; Sridhar V. Basavaraju; Matthew J. Kuehnert; Brenda Rivera-Garcia

Since November 2015, Puerto Rico has reported active mosquito-borne transmission of Zika virus. Because of the potential for Zika virus to be transmitted through transfusion of blood components, and because a high percentage of persons infected with Zika virus are asymptomatic, the Food and Drug Administration (FDA) recommended that blood collections cease in areas of the United States affected by active vector-borne transmission of Zika virus until laboratory screening of blood donations or pathogen reduction technology (PRT) for treatment of blood components can be implemented. To inform efforts to maintain the safety and availability of the blood supply in Puerto Rico, CDC, in collaboration with the Puerto Rico Department of Health, conducted a rapid assessment of blood collection and use on the island. A total of 139,369 allogeneic red blood cell (RBC) units, 45,243 platelet units, and 56,466 plasma units were collected in or imported to Puerto Rico during 2015, and 135,966 allogeneic RBC units, 13,526 therapeutic platelet units, and 25,775 plasma units were transfused. Because of the potential for local Zika virus transmission in areas with a competent mosquito vector, other areas of the United States should develop plans to ensure local blood safety and adequacy. Blood collection organizations and public health agencies should collaborate to maintain the safety and availability of local blood supplies in accordance with FDA guidance.


Journal of Clinical Microbiology | 2013

Evaluation of Quantification of HIV-1 RNA Viral Load in Plasma and Dried Blood Spots by Use of the Semiautomated Cobas Amplicor Assay and the Fully Automated Cobas Ampliprep/TaqMan Assay, Version 2.0, in Kisumu, Kenya

Kenneth Ouma; Sridhar V. Basavaraju; Jully A. Okonji; John Williamson; Timothy K. Thomas; Lisa A. Mills; John N. Nkengasong; Clement Zeh

ABSTRACT In Kenya, HIV-1 viral load monitoring is commonly performed with the Cobas Amplicor using plasma specimens. Interest is growing in transitioning to real-time PCR (RT-PCR), such as the Cobas Ampliprep/Cobas TaqMan (CAP/CTM), using dried blood spots (DBS). Before implementation, direct evaluation of the two assays using DBS field specimens is required. This study compares the sensitivity, specificity, negative and positive predictive values (NPV and PPV, respectively), concordance, and agreement between HIV-1 viral load measurements using plasma and DBS specimens obtained from 512 HIV-1-infected pregnant females enrolled in the Kisumu Breastfeeding Study and tested with the Cobas Amplicor and CAP/CTM assays. The sensitivity and NPV of viral load detection in DBS specimens were higher with CAP/CTM (sensitivity, 100%; 95% confidence interval [CI], 99.1 to 100.0%; NPV, 100%; 95% CI, 59.0 to 100.0%) than the Cobas Amplicor (sensitivity, 96.6%; 95% CI, 94.3 to 98.1%; NPV, 58.8%; 95% CI, 40.7 to 75.4%). The PPVs were comparable between both assays when using DBS. The specificity of viral load detection in DBS specimens was lower with CAP/CTM (77.8%; 95% CI, 40.0 to 97.2%) than that of the Cobas Amplicor (95.2%; 95% CI, 76.2 to 99.9%). Good concordance and agreement were observed when paired plasma and DBS specimens were tested with both assays. Lower specificity with the CAP/CTM is likely due to proviral HIV-1 DNA amplification and lower detection limits with RT-PCR. However, the CAP/CTM has better sensitivity and higher throughput than the Cobas Amplicor. These findings suggest that DBS may be a suitable alternative to plasma when using RT-PCR, which could increase access to viral load monitoring in resource-limited settings.


International journal of critical illness and injury science | 2012

Epidemiology and clinical characteristics of traumatic brain injuries in a rural setting in Maharashtra, India. 2007-2009

Amit Agrawal; Sagar Galwankar; Vikas Kapil; Victor G. Coronado; Sridhar V. Basavaraju; Lisa C. McGuire; Rajnish Joshi; Syed Z Quazi; Sankalp Dwivedi

Context: Though some studies have described traumatic brain injuries in tertiary care, urban hospitals in India, very limited information is available from rural settings. Aims: To evaluate and describe the epidemiological and clinical characteristics of patients with traumatic brain injury and their clinical outcomes following admission to a rural, tertiary care teaching hospital in India. Settings and Design: Retrospective, cross-sectional, hospital-based study from January 2007 to December 2009. Materials and Methods: Epidemiological and clinical data from all patients with traumatic brain injury (TBI) admitted to the neurosurgery service of a rural hospital in district Wardha, Maharashtra, India, from 2007 to 2009 were analyzed. The medical records of all eligible patients were reviewed and data collected on age, sex, place of residence, Glasgow Coma Scale (GCS) score, mechanism of injury, severity of injury, concurrent injuries, length of hospital stay, computed tomography (CT) scan results, type of management, indication and type of surgical intervention, and outcome. Statistical Analysis: Data analysis was performed using STATA version 11.0. Results: The medical records of 1,926 eligible patients with TBI were analyzed. The median age of the study population was 31 years (range <1 year to 98 years). The majority of TBI cases occurred in persons aged 21 - 30 years (535 or 27.7%), and in males (1,363 or 70.76%). Most patients resided in nearby rural areas and the most frequent external cause of injury was motor vehicle crash (56.3%). The overall TBI-related mortality during the study period was 6.4%. From 2007 to 2009, TBI-related mortality significantly decreased (P < 0.01) during each year (2007: 8.9%, 2008: 8.5%, and 2009: 4.9%). This decrease in mortality could be due to access and availability of better health care facilities. Conclusions: Road traffic crashes are the leading cause of TBI in rural Maharashtra ffecting mainly young adult males. At least 10% of survivors had moderate or more severe TBI-related disabilities. Future research should include prospective, population based studies to better elucidate the incidence, prevalence, and economic impact of TBI in rural India.


Morbidity and Mortality Weekly Report | 2016

Progress Toward Strengthening National Blood Transfusion Services - 14 Countries, 2011-2014.

Chevalier Ms; Matthew J. Kuehnert; Sridhar V. Basavaraju; Bjork A; Pitman Jp

Blood transfusion is a life-saving medical intervention; however, challenges to the recruitment of voluntary, unpaid or otherwise nonremunerated whole blood donors and insufficient funding of national blood services and programs have created obstacles to collecting adequate supplies of safe blood in developing countries (1). Since 2004, the U.S. Presidents Emergency Plan for AIDS Relief (PEPFAR) has provided approximately

Collaboration


Dive into the Sridhar V. Basavaraju's collaboration.

Top Co-Authors

Avatar

Matthew J. Kuehnert

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

John P. Pitman

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Koo-Whang Chung

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Ray W. Shiraishi

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

David W. Lowrance

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Sherif R. Zaki

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Anthony A. Marfin

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Clement Zeh

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Jane Mwangi

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Lawrence H. Marum

Centers for Disease Control and Prevention

View shared research outputs
Researchain Logo
Decentralizing Knowledge